Skip to main content
. 2015 May 1;15(10):1–64.

Table 5:

False-Positive Rate by ERSPC Participating Countries

  Italy Belgium Finland Sweden Netherlands
Screening frequency, years 4–7a 4 4 2 4
PSA threshold 3 ng/ml 3 ng/ml 4 ng/ml 3 ng/ml 3 ng/ml
False-positive rate, % 10.5 11.0 13.0 22.3 26.1

Abbreviations: ERSPC, European Randomized Study of Screening for Prostate Cancer; PSA, prostate specific antigen.

a

Screening frequency was 7 years initially, then 4 years.

Source: Kilpelainen et al, 2011. (74)